{"transactions":[{"id":816476,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-03T20:07:11.000Z","date":"2026-04-01","kind":"exercise","planned":true,"acquired":false,"shares":3383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on April 1, 2022, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":6.57,"expiration_date":"2032-05-28","underlying":"Common Stock","underlying_shares":3383},"source":{"system":"sec-edgar","filing":"0001210905-26-000011","document":"form4-04032026_080407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090526000011/form4-04032026_080407.xml","form_type":"4"}},{"id":816475,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-03T20:07:11.000Z","date":"2026-04-01","kind":"exercise","planned":true,"acquired":false,"shares":5437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested.  Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on May 11, 2024."}],"balance_after":0,"derivative":{"exercise_price":4.11,"expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":5437},"source":{"system":"sec-edgar","filing":"0001210905-26-000011","document":"form4-04032026_080407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090526000011/form4-04032026_080407.xml","form_type":"4"}},{"id":816474,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-03T20:07:11.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":8820,"price":17.81,"value":157084.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001210905-26-000011","document":"form4-04032026_080407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090526000011/form4-04032026_080407.xml","form_type":"4"}},{"id":816473,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-03T20:07:11.000Z","date":"2026-04-01","kind":"exercise","planned":true,"acquired":true,"shares":3383,"price":6.57,"value":22226.31,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024."}],"balance_after":8820,"source":{"system":"sec-edgar","filing":"0001210905-26-000011","document":"form4-04032026_080407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090526000011/form4-04032026_080407.xml","form_type":"4"}},{"id":816472,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-03T20:07:11.000Z","date":"2026-04-01","kind":"exercise","planned":true,"acquired":true,"shares":5437,"price":4.11,"value":22346.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024."}],"balance_after":5437,"source":{"system":"sec-edgar","filing":"0001210905-26-000011","document":"form4-04032026_080407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090526000011/form4-04032026_080407.xml","form_type":"4"}},{"id":867429,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T21:46:45.000Z","date":"2026-03-02","kind":"exercise","planned":true,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on April 1, 2022, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":3383,"derivative":{"exercise_price":6.57,"expiration_date":"2032-05-28","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001210905-26-000009","document":"form4-03032026_090341.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090526000009/form4-03032026_090341.xml","form_type":"4"}},{"id":867428,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T21:46:45.000Z","date":"2026-03-02","kind":"exercise","planned":true,"acquired":false,"shares":5433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested.  Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on May 11, 2024."}],"balance_after":5437,"derivative":{"exercise_price":4.11,"expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":5433},"source":{"system":"sec-edgar","filing":"0001210905-26-000009","document":"form4-03032026_090341.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090526000009/form4-03032026_090341.xml","form_type":"4"}},{"id":867427,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-03T21:46:45.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":7433,"price":20.3,"value":150889.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001210905-26-000009","document":"form4-03032026_090341.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090526000009/form4-03032026_090341.xml","form_type":"4"}},{"id":867426,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-03T21:46:45.000Z","date":"2026-03-02","kind":"exercise","planned":true,"acquired":true,"shares":2000,"price":6.57,"value":13140.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024."}],"balance_after":7433,"source":{"system":"sec-edgar","filing":"0001210905-26-000009","document":"form4-03032026_090341.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090526000009/form4-03032026_090341.xml","form_type":"4"}},{"id":867425,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-03T21:46:45.000Z","date":"2026-03-02","kind":"exercise","planned":true,"acquired":true,"shares":5433,"price":4.11,"value":22329.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024."}],"balance_after":5433,"source":{"system":"sec-edgar","filing":"0001210905-26-000009","document":"form4-03032026_090341.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090526000009/form4-03032026_090341.xml","form_type":"4"}},{"id":893415,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-19T21:42:42.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on February 1, 2026, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":110000,"derivative":{"exercise_price":19.63,"expiration_date":"2036-02-16","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001210905-26-000007","document":"form4-02192026_090237.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090526000007/form4-02192026_090237.xml","form_type":"4"}},{"id":921946,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-03T21:26:11.000Z","date":"2026-02-02","kind":"exercise","planned":true,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on April 1, 2022, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":5383,"derivative":{"exercise_price":6.57,"expiration_date":"2032-05-28","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001210905-26-000005","document":"form4-02032026_090207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090526000005/form4-02032026_090207.xml","form_type":"4"}},{"id":921945,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-03T21:26:11.000Z","date":"2026-02-02","kind":"exercise","planned":true,"acquired":false,"shares":5433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested.  Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on May 11, 2024."}],"balance_after":10870,"derivative":{"exercise_price":4.11,"expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":5433},"source":{"system":"sec-edgar","filing":"0001210905-26-000005","document":"form4-02032026_090207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090526000005/form4-02032026_090207.xml","form_type":"4"}},{"id":921944,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-03T21:26:11.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":7433,"price":18.75,"value":139368.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001210905-26-000005","document":"form4-02032026_090207.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090526000005/form4-02032026_090207.xml","form_type":"4"}},{"id":921943,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-03T21:26:11.000Z","date":"2026-02-02","kind":"exercise","planned":true,"acquired":true,"shares":2000,"price":6.57,"value":13140.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024."}],"balance_after":7433,"source":{"system":"sec-edgar","filing":"0001210905-26-000005","document":"form4-02032026_090207.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090526000005/form4-02032026_090207.xml","form_type":"4"}},{"id":921942,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-03T21:26:11.000Z","date":"2026-02-02","kind":"exercise","planned":true,"acquired":true,"shares":5433,"price":4.11,"value":22329.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024."}],"balance_after":5433,"source":{"system":"sec-edgar","filing":"0001210905-26-000005","document":"form4-02032026_090207.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090526000005/form4-02032026_090207.xml","form_type":"4"}},{"id":946823,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T21:24:01.000Z","date":"2026-01-02","kind":"exercise","planned":true,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on April 1, 2022, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":7383,"derivative":{"exercise_price":6.57,"expiration_date":"2032-05-28","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001210905-26-000002","document":"form4-01062026_090157.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090526000002/form4-01062026_090157.xml","form_type":"4"}},{"id":946822,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T21:24:01.000Z","date":"2026-01-02","kind":"exercise","planned":true,"acquired":false,"shares":5433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested.  Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on May 11, 2024."}],"balance_after":16303,"derivative":{"exercise_price":4.11,"expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":5433},"source":{"system":"sec-edgar","filing":"0001210905-26-000002","document":"form4-01062026_090157.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090526000002/form4-01062026_090157.xml","form_type":"4"}},{"id":946821,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-06T21:24:01.000Z","date":"2026-01-02","kind":"sale","planned":true,"acquired":false,"shares":7433,"price":12.8468,"value":95490.2644,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.571 to $13.242 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001210905-26-000002","document":"form4-01062026_090157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090526000002/form4-01062026_090157.xml","form_type":"4"}},{"id":946820,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-06T21:24:01.000Z","date":"2026-01-02","kind":"exercise","planned":true,"acquired":true,"shares":2000,"price":6.57,"value":13140.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024."}],"balance_after":7433,"source":{"system":"sec-edgar","filing":"0001210905-26-000002","document":"form4-01062026_090157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090526000002/form4-01062026_090157.xml","form_type":"4"}},{"id":946819,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-06T21:24:01.000Z","date":"2026-01-02","kind":"exercise","planned":true,"acquired":true,"shares":5433,"price":4.11,"value":22329.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024."}],"balance_after":5433,"source":{"system":"sec-edgar","filing":"0001210905-26-000002","document":"form4-01062026_090157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090526000002/form4-01062026_090157.xml","form_type":"4"}},{"id":972681,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-11T21:21:15.000Z","date":"2025-12-09","kind":"exercise","planned":true,"acquired":false,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on April 1, 2022, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":9383,"derivative":{"exercise_price":6.57,"expiration_date":"2032-05-28","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001210905-25-000006","document":"form4-12112025_091211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090525000006/form4-12112025_091211.xml","form_type":"4"}},{"id":972680,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-11T21:21:15.000Z","date":"2025-12-09","kind":"sale","planned":true,"acquired":false,"shares":18000,"price":12,"value":216000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001210905-25-000006","document":"form4-12112025_091211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090525000006/form4-12112025_091211.xml","form_type":"4"}},{"id":972679,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-11T21:21:15.000Z","date":"2025-12-09","kind":"exercise","planned":true,"acquired":true,"shares":18000,"price":6.57,"value":118260.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024."}],"balance_after":18000,"source":{"system":"sec-edgar","filing":"0001210905-25-000006","document":"form4-12112025_091211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090525000006/form4-12112025_091211.xml","form_type":"4"}},{"id":979057,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-05T23:20:44.000Z","date":"2025-12-04","kind":"exercise","planned":true,"acquired":false,"shares":68897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested.  Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on May 11, 2024."}],"balance_after":21736,"derivative":{"exercise_price":4.11,"expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":68897},"source":{"system":"sec-edgar","filing":"0001210905-25-000004","document":"form4-12052025_111241.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090525000004/form4-12052025_111241.xml","form_type":"4"}},{"id":979056,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-05T23:20:44.000Z","date":"2025-12-04","kind":"sale","planned":true,"acquired":false,"shares":68897,"price":10.1878,"value":701908.8566,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.96 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001210905-25-000004","document":"form4-12052025_111241.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090525000004/form4-12052025_111241.xml","form_type":"4"}},{"id":979055,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-05T23:20:44.000Z","date":"2025-12-04","kind":"exercise","planned":true,"acquired":true,"shares":68897,"price":4.11,"value":283166.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024."}],"balance_after":68897,"source":{"system":"sec-edgar","filing":"0001210905-25-000004","document":"form4-12052025_111241.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000121090525000004/form4-12052025_111241.xml","form_type":"4"}},{"id":1255825,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-20T21:22:32.000Z","date":"2025-02-18","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on February 1, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":200000,"derivative":{"exercise_price":4.38,"expiration_date":"2035-02-17","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001415889-25-004867","document":"form4-02202025_090226.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000141588925004867/form4-02202025_090226.xml","form_type":"4"}},{"id":3667822,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-08T21:34:56.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":87000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2016 Equity Incentive Plan (the \"Plan\"). 6.25% of the shares will vest on May 7, 2019 and the remaining 93.75% of the shares will vest in equal monthly installments thereafter over 45 months, such that the stock option shall be fully vested on the four-year anniversary of the date of grant, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan. The shares underlying the option are subject to accelerated vesting upon the occurrence of specified events including a change of control of the Issuer and the Reporting Person's termination. The option expires ten years after the date of grant."}],"balance_after":87000,"derivative":{"exercise_price":2.96,"expiration_date":"2029-02-05","underlying":"Common Stock","underlying_shares":87000},"source":{"system":"sec-edgar","filing":"0001209191-19-008542","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210905/000120919119008542/doc4.xml","form_type":"4"}},{"id":4078819,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-03T01:15:01.000Z","date":"2018-01-31","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2016 Equity Incentive Plan (the \"Plan\"). 6.25% of the shares will vest on April 30, 2018 and the remaining 93.75% of the shares will vest in equal monthly installments thereafter over 45 months, such that the stock option shall be fully vested on the four-year anniversary of the date of grant, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan. The shares underlying the option are subject to accelerated vesting upon the occurrence of specified events including a change of control of the Issuer and the Reporting Person's termination. The option expires ten years after the date of grant."}],"balance_after":85000,"derivative":{"exercise_price":7.5,"expiration_date":"2028-01-30","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001209191-18-007264","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210905/000120919118007264/doc4.xml","form_type":"4"}},{"id":4442235,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":53847,"kind":"person","name":"RUBIN PAUL D","position":1,"cik":"0001210905","reported_name":"RUBIN PAUL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-17T01:26:33.000Z","date":"2017-02-16","kind":"grant","acquired":true,"shares":87500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2016 Equity Incentive Plan (the \"Plan\"). The shares vest in 48 equal monthly installments beginning on February 16, 2017, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan. The shares underlying the option are subject to accelerated vesting upon the occurrence of specified events including a change of control of the Issuer and the Reporting Person's termination. The option expires ten years after the date of grant."}],"balance_after":87500,"derivative":{"exercise_price":11.01,"expiration_date":"2027-02-15","underlying":"Common Stock","underlying_shares":87500},"source":{"system":"sec-edgar","filing":"0001209191-17-011781","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210905/000120919117011781/doc4.xml","form_type":"4"}}]}